Biotech First patient enrollment in the U.S. – A milestone for the global multi-center phase Ⅲ clinical trial of telitacicept for myasthenia gravis August 6, 2024
Biotech Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery August 5, 2024
Biotech Invitation to the presentation of Calliditas´s interim report January – June 2024 August 5, 2024
Biotech Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine August 3, 2024
Biotech Advanced Electrophoresis Solutions Ltd. (AES) Announces Strategic Executive Appointments to Drive Innovation and Growth August 3, 2024
Biotech Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets August 2, 2024
Biotech Myeloid Therapeutics to Participate in Barclays Biotech: 1×1 Private Company Symposium August 2, 2024